RS20060189A - Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje - Google Patents

Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje

Info

Publication number
RS20060189A
RS20060189A YUP-2006/0189A YUP20060189A RS20060189A RS 20060189 A RS20060189 A RS 20060189A YU P20060189 A YUP20060189 A YU P20060189A RS 20060189 A RS20060189 A RS 20060189A
Authority
RS
Serbia
Prior art keywords
hydroxy
acetone
dimethoxy
benzoyloxy
acetoxy
Prior art date
Application number
YUP-2006/0189A
Other languages
English (en)
Serbian (sr)
Inventor
Eric Didier
Marc-Antoine Perrin
Original Assignee
Aventis Pharma S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS20060189(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,
Publication of RS20060189A publication Critical patent/RS20060189A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YUP-2006/0189A 2003-09-19 2004-09-16 Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje RS20060189A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311016A FR2859996B1 (fr) 2003-09-19 2003-09-19 Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PCT/FR2004/002344 WO2005028462A1 (fr) 2003-09-19 2004-09-16 Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Publications (1)

Publication Number Publication Date
RS20060189A true RS20060189A (sr) 2008-06-05

Family

ID=34224354

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20060189A RS54614B1 (sr) 2003-09-19 2004-09-16 Acetonski solvat dimetoksi docetaksela i postupak za njegovo dobijanje
YUP-2006/0189A RS20060189A (sr) 2003-09-19 2004-09-16 Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RS20060189A RS54614B1 (sr) 2003-09-19 2004-09-16 Acetonski solvat dimetoksi docetaksela i postupak za njegovo dobijanje

Country Status (37)

Country Link
US (1) US7241907B2 (enExample)
EP (1) EP1667986B1 (enExample)
JP (1) JP5010279B2 (enExample)
KR (1) KR101123588B1 (enExample)
CN (1) CN100429207C (enExample)
AR (1) AR045667A1 (enExample)
AU (1) AU2004274212B2 (enExample)
BE (1) BE2013C036I2 (enExample)
BR (1) BRPI0414492A8 (enExample)
CA (1) CA2539309A1 (enExample)
CR (1) CR8292A (enExample)
CY (2) CY1114575T1 (enExample)
DK (1) DK1667986T3 (enExample)
ES (1) ES2403149T4 (enExample)
FR (2) FR2859996B1 (enExample)
HR (1) HRP20130322T1 (enExample)
HU (1) HUS1300025I1 (enExample)
IL (1) IL174240A (enExample)
LU (1) LU92172I2 (enExample)
MA (1) MA28045A1 (enExample)
ME (2) ME00054B (enExample)
MX (1) MXPA06002639A (enExample)
MY (1) MY136668A (enExample)
NO (2) NO335997B1 (enExample)
NZ (1) NZ545835A (enExample)
PA (1) PA8612401A1 (enExample)
PE (1) PE20050870A1 (enExample)
PL (1) PL1667986T3 (enExample)
PT (1) PT1667986E (enExample)
RS (2) RS54614B1 (enExample)
RU (1) RU2342373C2 (enExample)
SI (1) SI1667986T1 (enExample)
TN (1) TNSN06086A1 (enExample)
TW (1) TWI382022B (enExample)
UA (1) UA87115C2 (enExample)
WO (1) WO2005028462A1 (enExample)
ZA (1) ZA200602255B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
US7855591B2 (en) * 2006-06-07 2010-12-21 Atmel Corporation Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) * 2006-09-05 2010-01-26 Atmel Corporation High efficiency low cost bi-directional charge pump circuit for very low voltage applications
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
AU2013205442B2 (en) * 2008-01-17 2016-05-12 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
CN102159250B (zh) 2008-08-11 2014-08-06 尼克塔治疗公司 多臂的聚合烷酸酯偶联物
FR2945211A1 (fr) * 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
CA2708489A1 (en) * 2009-10-29 2011-04-29 Aventis Pharma S.A. Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
WO2011051894A1 (en) * 2009-10-29 2011-05-05 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
AU2015200149B2 (en) * 2009-10-29 2016-12-01 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
EP2688877B1 (en) 2011-04-12 2017-03-08 Teva Pharmaceuticals International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
WO2013072766A2 (en) 2011-10-31 2013-05-23 Scinopharm Taiwan, Ltd. Process for cabazitaxel and intermediates thereof
DE112012004569T5 (de) 2011-11-01 2014-08-14 Fresenius Kabi Oncology Ltd. Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
PL2785701T3 (pl) * 2011-11-28 2019-08-30 Fresenius Kabi Oncology Limited Krystaliczna postać kabazytakselu i sposób jej otrzymywania
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
WO2013111157A1 (en) * 2012-01-03 2013-08-01 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
EA201491506A1 (ru) * 2012-02-10 2014-12-30 Авентис Фарма С.А. Новое применение кабазитаксела в педиатрии
CN104220431A (zh) 2012-03-08 2014-12-17 伊瓦克斯国际有限责任公司 卡巴他赛的固态形式及其制备方法
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
CN104583189A (zh) 2012-07-31 2015-04-29 永信药品工业股份有限公司 非晶型的卡巴利他索
US9198969B2 (en) 2012-08-15 2015-12-01 Yung Shin Pharm. Ind. Co., Ltd. Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
EP2777691A1 (en) 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
CN104277014A (zh) * 2013-07-04 2015-01-14 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
US20180311203A1 (en) 2015-01-12 2018-11-01 Emcure Pharmaceuticals Limited Liquid formulation of cabazitaxel
WO2016133387A1 (en) 2015-02-17 2016-08-25 Erasmus University Medical Center Rotterdam Use of cabazitaxel in the treatment of prostate cancer
EP3093014A1 (en) 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
MA46972A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Forme polymorphe de sépiaptérine
NZ753504A (en) 2016-11-29 2025-10-31 Ptc Therapeutics Mp Inc Polymorphs of sepiapterin and salts thereof
CN111491635A (zh) 2017-09-01 2020-08-04 显莎制药公司 包含墨蝶呤的药物组合物及其用途
JP7547215B2 (ja) 2018-05-30 2024-09-09 ピーティーシー セラピューティクス エムピー，インコーポレイテッド テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法
US11617752B2 (en) 2018-05-30 2023-04-04 Ptc Therapeutics Mp, Inc. Methods for increasing sepiapterin plasma exposure
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
DE4425978C1 (de) * 1994-07-22 1995-11-23 Karlsruhe Forschzent Verfahren zur Herstellung keramischer Mikrostrukturen
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
AU761389B2 (en) * 1999-05-17 2003-06-05 Bristol-Myers Squibb Company Novel reaction conditions for the cleavage of silyl ethers in the preparation of paclitaxel (taxol) and paclitaxel analogues
PT1457492E (pt) * 2001-11-29 2008-02-28 Daiichi Sankyo Co Ltd Cristais de um derivado de taxano e processo para a sua produção

Also Published As

Publication number Publication date
EP1667986A1 (fr) 2006-06-14
NO2015013I1 (no) 2015-05-04
FR2859996B1 (fr) 2006-02-03
MA28045A1 (fr) 2006-07-03
KR20060072147A (ko) 2006-06-27
MXPA06002639A (es) 2006-06-05
HK1093340A1 (zh) 2007-03-02
AU2004274212A1 (en) 2005-03-31
FR13C0037I2 (fr) 2015-11-20
ES2403149T3 (es) 2013-05-14
TWI382022B (zh) 2013-01-11
RS54614B1 (sr) 2016-08-31
SI1667986T1 (sl) 2013-05-31
WO2005028462A1 (fr) 2005-03-31
KR101123588B1 (ko) 2012-03-22
BRPI0414492A (pt) 2006-11-14
HUS1300025I1 (hu) 2016-08-29
NO2015013I2 (no) 2015-04-22
TW200524891A (en) 2005-08-01
US20050065138A1 (en) 2005-03-24
JP2007505866A (ja) 2007-03-15
CN100429207C (zh) 2008-10-29
NO335997B1 (no) 2015-04-20
TNSN06086A1 (en) 2007-10-03
MY136668A (en) 2008-11-28
NO20061714L (no) 2006-04-19
IL174240A (en) 2010-12-30
BE2013C036I2 (enExample) 2023-12-14
PT1667986E (pt) 2013-04-24
RU2006113122A (ru) 2006-08-27
CY2013016I2 (el) 2018-01-10
HRP20130322T1 (en) 2013-07-31
BRPI0414492A8 (pt) 2019-01-15
CY1114575T1 (el) 2016-10-05
AR045667A1 (es) 2005-11-02
ME00054B (me) 2011-02-10
PL1667986T3 (pl) 2013-06-28
UA87115C2 (ru) 2009-06-25
LU92172I2 (fr) 2013-05-21
LU92172I9 (enExample) 2019-01-03
ZA200602255B (en) 2007-07-25
CY2013016I1 (el) 2018-01-10
IL174240A0 (en) 2006-08-01
FR13C0037I1 (fr) 2013-09-08
JP5010279B2 (ja) 2012-08-29
AU2004274212B2 (en) 2010-03-04
EP1667986B1 (fr) 2013-01-16
PE20050870A1 (es) 2005-11-21
CR8292A (es) 2008-10-15
US7241907B2 (en) 2007-07-10
ES2403149T4 (es) 2013-06-24
DK1667986T3 (da) 2013-05-06
PA8612401A1 (es) 2005-08-04
CN1849311A (zh) 2006-10-18
NZ545835A (en) 2009-10-30
CA2539309A1 (fr) 2005-03-31
RU2342373C2 (ru) 2008-12-27
MEP11708A (en) 2010-06-10
FR2859996A1 (fr) 2005-03-25

Similar Documents

Publication Publication Date Title
RS20060189A (sr) Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje
KR100391753B1 (ko) 4-아세톡시-2α-벤조일옥시-5β,2O-에폭시-1,7β,10β-트리하이드록시-9-옥소-택스-11-엔-13α-일(2R,3S)-3-3급-부톡시카보닐아미노-2-하이드록시-3-페닐프로피오네이트삼수화물의제조방법
JP7028795B2 (ja) グルタチオントリスルフィド・２水和物の結晶及びその製造方法
CN110759833B (zh) 4-羟基-苯甲基(2’-羟基-苯亚甲基)-酰肼的制备方法及其应用
HU179435B (en) Diagnostical instrument for detecting leukocytes in body-liquides and process for producing reagents for the colourreactions
JPH0791302B2 (ja) エラグ酸の製造法
CN103467552B (zh) 8-环己基-2-氟阿糖腺苷、制备方法及其应用
FR2491928A1 (fr) Cristaux de b-nicotinamide adenine dinucleotide et procede de leur preparation
RO111677B1 (ro) Procedeu si intermediar pentru prepararea oxitetraciclinei pure
HK1093340B (en) Dimethoxy docetaxel acetone solvate et method for the preparation thereof
JP4564375B2 (ja) テアニンの製造方法
FR2465785A1 (fr) Procede pour determiner l'activite de l'enzyme transformant l'angiotensine
Al-Farhan et al. A Simple synthesis of cyclotribromoveratrylene (CTBV) an extractive of the red alga Halopytis pinastroides
SU829058A1 (ru) Гаметоциды дл пшеницы и ржи
SU1476856A1 (ru) @ -Азидоциннамоилазины как светочувствительные компоненты фотополимеризующейс композиции
KR100461585B1 (ko) 데커신 유도체
RU2412959C1 (ru) Полимерный хемосенсорный материал
CN120518670A (zh) 一种可区分检测H2S与HClO的双功能荧光探针制备方法和用途
SU799390A1 (ru) Способ получени калиевой соли бис [1 - (4 @ -сульфофенил)-3-карбоксипиразолон-5]-триметиноксанина
JPH03258772A (ja) ４（又は７）―ヒドラジノ―２，１，３―ベンゾオキサジアゾール誘導体またはその塩
JP2003040858A (ja) ビニルスルホンの品質劣化防止方法並びに精製方法
JPWO2020013330A1 (ja) ユーコミン酸の非溶媒和物結晶及びその製造方法
MXPA99001306A (en) Antibacterial compounds for ralstonia solanacea